186 related articles for article (PubMed ID: 7755378)
1. [Human papilloma virus and cervical cancer].
Kawana T
Gan To Kagaku Ryoho; 1995 May; 22(6):711-7. PubMed ID: 7755378
[TBL] [Abstract][Full Text] [Related]
2. HPV-16-related proteins as the serologic markers in cervical neoplasia.
Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
[TBL] [Abstract][Full Text] [Related]
3. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
4. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
[TBL] [Abstract][Full Text] [Related]
5. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
6. Detection of human papillomavirus DNA, serum p53, and p53 antibodies in patients with cervical cancer.
Sobti RC; Parashar K; Kaur R; Capalash N
J Environ Pathol Toxicol Oncol; 2002; 21(1):79-85. PubMed ID: 11934017
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
8. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.
Fisher SG; Benitez-Bribiesca L; Nindl I; Stockfleth E; Muller M; Wolf H; Perez-Garcia F; Guzman-Gaona J; Gutierrez-Delgado F; Irvin W; Gissmann L
Gynecol Oncol; 1996 Apr; 61(1):73-8. PubMed ID: 8626121
[TBL] [Abstract][Full Text] [Related]
9. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD
Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744
[TBL] [Abstract][Full Text] [Related]
11. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
12. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions.
Cento V; Ciccozzi M; Ronga L; Perno CF; Ciotti M
J Med Virol; 2009 Sep; 81(9):1627-34. PubMed ID: 19626616
[TBL] [Abstract][Full Text] [Related]
13. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of human papilloma virus-DNA in condyloma acuminatum, cervical cancer and the female genital tract].
Cui M; Zheng P; Huang B
Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):163-5. PubMed ID: 8758791
[TBL] [Abstract][Full Text] [Related]
15. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
[TBL] [Abstract][Full Text] [Related]
16. Papillomavirus genomes in human cervical carcinoma: analysis of their integration and transcriptional activity.
Matulić M; Sorić J
Neoplasma; 1994; 41(2):95-100. PubMed ID: 8208320
[TBL] [Abstract][Full Text] [Related]
17. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
[TBL] [Abstract][Full Text] [Related]
18. Frequent detection of human papilloma viruses in cervical dysplasia by PCR single-strand DNA-conformational polymorphism analysis.
Nakagawa H; Sugano K; Fujii T; Kubushiro K; Tsukazaki K; Nozawa S
Anticancer Res; 2002; 22(3):1655-60. PubMed ID: 12168850
[TBL] [Abstract][Full Text] [Related]
19. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
20. [Papillomavirus and cancer].
Hakura A
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2011-21. PubMed ID: 2840032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
